News for EyePoint Pharmaceuticals, Inc. (EYPT)

Published at

Jul 16, 2025 2:22 PM

by gurufocus.com

positive

positive

EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | EYPT Stock News

EyePoint Pharmaceuticals (EYPT) grants inducement stock options to new employees. The options cover a total of 63,900 shares with a ten-year term and a

EYPT

Read more →
Published at

Jul 16, 2025 2:18 PM

by gurufocus.com

positive

positive

EyePoint (EYPT) Awards Stock Options to New Employees as Inducement | EYPT Stock News

EyePoint Pharmaceuticals (EYPT) has announced the allocation of non-statutory stock options to new employees as part of inducement awards. These awards are offe

EYPT

Read more →
Published at

Jul 16, 2025 2:00 PM

by gurufocus.com

positive

positive

EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

WATERTOWN, Mass., July 16, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. ( EYPT), a company committed to developing and commercializing therapeutics

EYPT

Read more →
Published at

Jul 15, 2025 3:31 AM

by gurufocus.com

positive

positive

FEDERATED HERMES, INC. Acquires Additional Shares in EyePoint Pharmaceuticals Inc

On June 30, 2025, FEDERATED HERMES, INC. (Trades, Portfolio) executed a significant transaction by acquiring an additional 513,870 shares of EyePoint Pharmaceut

MSFTD.BA MSFTCL.SN MSFTC.BA MSFTB.BA MSFT.MI FHI EYPT APC.DE AMZNCL.SN AMZN.SN AMZN.MX AMZN AMZ.DE AAPLD.BA AAPLCL.SN AAPLC.BA AAPL.SN AAPL.NE AAPL.MX AAPL.BA AAPL

Read more →
Published at

Jun 17, 2025 6:30 PM

by gurufocus.com

positive

positive

RBC Capital Initiates Coverage on EyePoint Pharmaceuticals (EYPT) | EYPT Stock News

On June 17, 2025, RBC Capital initiated coverage on EyePoint Pharmaceuticals (EYPT) with an "Outperform" rating. This new coverage by RBC Capital analyst Lisa W

EYPT

Read more →
Published at

Jun 17, 2025 2:32 PM

by gurufocus.com

positive

positive

EyePoint Pharmaceuticals (EYPT) Poised for Success with Positive Outlook | EYPT Stock News

RBC Capital has initiated coverage on EyePoint Pharmaceuticals (EYPT) with an optimistic "Outperform" rating and set a price target of $28. The bank is confiden

EYPT

Read more →
Published at

Jun 16, 2025 2:47 PM

by gurufocus.com

positive

positive

EyePoint (EYPT) Grants Stock Options to New Employees as Inducement | EYPT Stock News

EyePoint Pharmaceuticals (EYPT) has awarded non-statutory stock options to new hires as an inducement for joining the company, outside of its 2023 Long-Term Inc

EYPT

Read more →
Published at

Jun 16, 2025 2:20 PM

by gurufocus.com

positive

positive

EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | EYPT Stock News

EyePoint Pharmaceuticals (EYPT) grants stock options to three new employees as inducement awards. The stock options cover 12,500 shares with an exercise

EYPT

Read more →
Published at

Jun 9, 2025 6:08 PM

by investing.com

mixed

mixed

Breakout Momentum Plays You May Not Know About

Market Analysis by covering: Nova Measuring Instruments Ltd, Eyepoint Pharmaceuticals Inc, Komatsu Ltd, Ouster Inc. Read 's Market Analysis on Investing.com

OUST-WT OUST EYPT BPOPO

Read more →
Published at

May 29, 2025 7:32 PM

by gurufocus.com

positive

positive

EyePoint Pharmaceuticals (EYPT) Reiterates Buy Rating with $22 Price Target | EYPT Stock News

EyePoint Pharmaceuticals (EYPT) has received a reiterated rating of "Buy" from HC Wainwright & Co., according to the latest report dated May 29, 2025. Analyst Y

EYPT

Read more →
Published at

May 28, 2025 4:23 PM

by benzinga.com

mixed

mixed

Heico, Monro, Abercrombie & Fitch, Joby Aviation And Other Big Stocks Moving Higher On Wednesday - AnaptysBio (NASDAQ:ANAB), Abercrombie & Fitch (NYSE:ANF)

U.S. stocks were slightly lower, with the Dow Jones index falling around 0.1% on Wednesday. Shares of HEICO Corporation HEI rose sharply during Wednesday's ses...

U2ST34.SA U.MX U MTN MNRO ITOS HEI-A HEI H1EI34.SA EYPT CPRIN.MX CPRI CNDT BOX ANF ANAB AFT.DE 0R32.L 0LK3.L 0J46.L 0HP1.L 0HFQ.L JOBY CTMX

Read more →
Published at

May 27, 2025 2:16 PM

by gurufocus.com

positive

positive

EyePoint (EYPT) Surpasses Enrollment Goal in Key Phase 3 Trial | EYPT Stock News

EyePoint Pharmaceuticals (EYPT) has successfully enrolled and randomized more than 400 patients in its crucial Phase 3 LUGANO trial for DURAVYU, a treatment tar

EYPT

Read more →
Published at

May 27, 2025 2:00 PM

by gurufocus.com

positive

positive

EyePoint Completes Enrollment in Pivotal Phase 3 LUGANO Trial of DURAVYU™ for Treatment of Wet Age-Related Macular Degeneration

”“ Over 400 patients enrolled and randomized over a seven-month period, driven by strong physician and patient interest ”“ ”“ LUCIA pivotal Phase 3 trial c

EYPT

Read more →
Published at

May 20, 2025 1:02 AM

by gurufocus.com

positive

positive

Insider Buying: Karen Zaderej Acquires Additional Shares of EyePoint Pharmaceuticals Inc (EYPT)

On May 19, 2025, Karen Zaderej, a Director at EyePoint Pharmaceuticals Inc (EYPT), purchased 10,000 shares of the company. Following this transaction, the insid

EYPT

Read more →
Published at

May 16, 2025 2:20 PM

by gurufocus.com

positive

positive

EyePoint (EYPT) Grants Stock Options to New Employees as Inducement Awards | EYPT Stock News

EyePoint Pharmaceuticals, under the ticker EYPT, has announced the issuance of non-statutory stock options to a group of new hires. These inducement awards, mad

EYPT

Read more →
Published at

May 16, 2025 2:18 PM

by gurufocus.com

positive

positive

EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | EYPT Stock News

EyePoint Pharmaceuticals (EYPT) grants stock options to seven new employees as inducement awards. The options allow purchase of up to 136,700 shares at

EYPT

Read more →
Published at

May 16, 2025 1:01 AM

by gurufocus.com

positive

positive

Insider Buying: Karen Zaderej Acquires Additional Shares of EyePoint Pharmaceuticals Inc (EYPT)

On May 15, 2025, Karen Zaderej, a Director at EyePoint Pharmaceuticals Inc (EYPT), purchased 10,000 shares of the company. Following this transaction, the insid

EYPT

Read more →
Published at

May 7, 2025 8:49 PM

by seekingalpha.com

neutral

neutral

EyePoint Pharmaceuticals, Inc. (EYPT) Q1 2025 Earnings Call Transcript

EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Q1 2025 Earnings Conference Call May 7, 2025 8:30 AM ETCompany ParticipantsGeorge Elston - Executive Vice...

EYPT

Read more →
Published at

May 7, 2025 4:52 PM

by seekingalpha.com

neutral

neutral

EyePoint Pharmaceuticals, Inc. 2025 Q1 - Results - Earnings Call Presentation (NASDAQ:EYPT)

The following slide deck was published by EyePoint Pharmaceuticals, Inc.

EYPT

Read more →
Published at

May 7, 2025 3:30 PM

by zacks.com

neutral

neutral

EyePoint Pharmaceuticals (EYPT) Reports Q1 Earnings: What Key Metrics Have to Say

The headline numbers for EyePoint Pharmaceuticals (EYPT) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

EYPT

Read more →